Denali Therapeutics Inc. (DNLI)
NASDAQ·Healthcare·Biotechnology
$19.22
—
Mkt Cap $2.94B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (24 analysts)
$33.67
Range $26.00 – $41.00
Implied Upside
+75.2%
Consensus $33.67 vs current $19.22
NASDAQ·Healthcare·Biotechnology
$19.22
—
Mkt Cap $2.94B
Buy
8
Hold
0
Sell
0
Price Target (24 analysts)
$33.67
Range $26.00 – $41.00
+75.2%
Consensus $33.67 vs current $19.22